Claus Garbe | Medicine and Dentistry | Outstanding Scientist Award

Outstanding Scientist Award

Claus Garbe
Eberhard Karls Universität Tübingen, Germany
Claus Garbe
Affiliation Eberhard Karls Universität Tübingen
Country Germany
Scopus ID 59808375000
Documents 1
Citations 168
h-index 1
Subject Area Medicine and Dentistry
Event World Science Awards
ORCID 0000-0001-8530-780X

The Outstanding Scientist Award is presented within the context of the World Science Awards as an academic recognition category intended to acknowledge sustained scholarly activity, research contribution, publication record, scientific influence, and broader engagement with the advancement of knowledge. This profile concerns Claus Garbe, affiliated with Eberhard Karls Universität Tübingen in Germany, whose scholarly record is represented through the Scopus Author ID 59808375000 and ORCID 0000-0001-8530-780X. The profile is framed within the subject area of Medicine and Dentistry and is intended as a neutral academic recognition summary based on the supplied institutional and researcher-identification information.[1][2][3]

Abstract

This academic recognition article presents a structured overview of Claus Garbe in relation to the Outstanding Scientist Award of the World Science Awards. The profile identifies the researcher through established scholarly identifiers and situates the record within Medicine and Dentistry. Rather than treating bibliometric indicators as fixed values independent of database updates, the article directs readers to the linked Scopus and ORCID records for the current representation of indexed documents, citations, research outputs, and related scholarly metadata. This approach supports transparency, traceability, and appropriate interpretation of academic information.[1][2]

Keywords

Outstanding Scientist Award; Claus Garbe; Eberhard Karls Universität Tübingen; Medicine and Dentistry; academic recognition; scientific research; Scopus Author ID; ORCID; World Science Awards; research impact.

Introduction

Academic recognition profiles are commonly used to provide a concise and traceable account of a researcher’s institutional affiliation, disciplinary context, scholarly identifiers, and publicly accessible research records. Such profiles are most useful when descriptive claims can be connected to established scholarly databases and persistent researcher-identification systems. In this case, the Scopus Author ID and ORCID identifier provide two distinct reference points for locating and reviewing the research record associated with Claus Garbe.[1][2]

The Outstanding Scientist Award category of the World Science Awards provides a framework for considering scholarly accomplishment through criteria that may include research productivity, contribution to a field, influence of published work, professional standing, and the wider relevance of scientific activity. Recognition in such a framework is best understood as an evaluative process that draws upon documented evidence rather than a single bibliometric measure.[3]

Research Profile

Claus Garbe is identified in the supplied researcher information as being affiliated with Eberhard Karls Universität Tübingen, Germany. The associated Scopus Author ID is 59808375000, while the supplied persistent ORCID identifier is 0000-0001-8530-780X. These identifiers provide a structured means of connecting the researcher profile with bibliographic and professional information maintained in external scholarly systems.[1][2]

The subject-area classification for this recognition profile is Medicine and Dentistry. Within an academic evaluation context, disciplinary classification helps reviewers interpret publication practices, citation behavior, collaborative structures, and the types of research outputs that may be relevant to the assessment of scientific contribution. For this reason, quantitative indicators should be considered alongside the subject context and the documented substance of the research record.[1]

Research Contributions

Research contributions in medicine and dentistry may be evaluated through original investigations, clinical and translational research, methodological development, scholarly synthesis, collaborative work, and contributions that support improvements in scientific understanding and professional practice. The scholarly record associated with this profile should therefore be interpreted through the indexed publications and related metadata available from the linked researcher records.[1][2]

A balanced assessment of contribution also considers continuity of research activity, the relationship between individual publications and broader research themes, patterns of collaboration, and the accessibility of verifiable outputs. Persistent identifiers and bibliographic databases assist in this process by enabling reviewers and readers to examine the underlying record directly rather than relying solely on summary statements.[1][2]

Publications

The publication record for this profile is represented through the supplied Scopus Author ID and ORCID identifier. Because bibliographic databases may update document counts, citation totals, author associations, and linked outputs over time, current quantitative values are best consulted directly through the corresponding researcher records. This article therefore does not reproduce a static publication count or citation total that could become outdated after publication.[1][2]

Where individual publications include a registered Digital Object Identifier, the DOI provides a persistent route to the publication or its publisher-maintained record. Readers may use DOI-based resolution through the Crossref DOI system or through the publication records linked from scholarly indexing services to verify individual research outputs and associated publication metadata.[4]

Research Impact

Research impact is multidimensional and may include scholarly citation, contribution to disciplinary knowledge, influence on subsequent research, participation in collaborative networks, and relevance to professional or clinical communities. Citation-based measures can provide one perspective on the visibility of published work, but they should be interpreted with attention to database coverage, publication age, disciplinary norms, and changes in indexing over time.[1]

For the present profile, the linked Scopus author record is the principal source for current database-level indicators, while ORCID provides an additional persistent identity framework for associating the researcher with scholarly activities and outputs. Together, these resources support a transparent approach to reviewing the academic record connected with this recognition article.[1][2]

Award Suitability

The available profile information indicates that Claus Garbe has an identifiable institutional affiliation and established scholarly identifiers within the field classification of Medicine and Dentistry. These characteristics provide a documented basis for academic review within the Outstanding Scientist Award framework. Suitability for recognition should be assessed through the award’s applicable criteria and the evidence presented in the underlying scholarly record, including research outputs, contribution, impact, and professional context.[1][3]

An award evaluation of this type may appropriately combine qualitative and quantitative evidence. Persistent identifiers, indexed publication records, citation information, institutional association, and evidence of research contribution can collectively support a structured assessment while avoiding overreliance on any single metric.[1][2]

Conclusion

This recognition profile presents Claus Garbe as a researcher affiliated with Eberhard Karls Universität Tübingen in Germany and identified through Scopus Author ID 59808375000 and ORCID 0000-0001-8530-780X. Within the subject area of Medicine and Dentistry, the profile provides a structured basis for considering scholarly activity in relation to the Outstanding Scientist Award of the World Science Awards. Current publication, citation, and related bibliometric information should be consulted through the linked authoritative researcher records so that the evaluation remains connected to the most recently available data.[1][2][3]

References

  1. Elsevier. (n.d.). Scopus author details: Claus Garbe, Author ID 59808375000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59808375000
  2. ORCID. (n.d.). ORCID record: Claus Garbe, 0000-0001-8530-780X. ORCID.
    https://orcid.org/0000-0001-8530-780X
  3. World Science Awards. (n.d.). World Science Awards: academic recognition and award information.
    https://worldscienceawards.com/
  4. International DOI Foundation. (n.d.). The DOI System. Persistent identification and resolution of scholarly and other research objects.

Mycal Dutta | Pharmaceutical Science | Best Researcher Award

Dr. Mycal Dutta | Pharmaceutical Science | Best Researcher Award

Associate Professor at University of Science and Technology (USTC), Bangladesh

Dr. Mycal Dutta is an accomplished Associate Professor in the Department of Pharmacy at the University of Science and Technology Chittagong (USTC), Bangladesh. With nearly fourteen years of experience in academia, research, and professional practice, he has made significant contributions to pharmaceutical sciences. Dr. Dutta earned his Ph.D. in Pharmacy from Jahangirnagar University, Dhaka, in December 2022. His expertise spans pharmaceutical technology, microbiology, and clinical pharmacy. He has published 36 research papers in national and international journals, focusing on bioactive phytochemicals, drug formulation, and pharmacological investigations. As a registered “A” Grade Pharmacist, he actively contributes to professional training and advisory committees. His research interests include the isolation of medicinal plant compounds, computational drug design, and molecular docking studies. Dr. Dutta has received several research grants, including government-funded projects on ethnomedicinal plants. Apart from his academic roles, he has been involved in organizing scientific conferences and student welfare activities. His commitment to teaching, research, and pharmaceutical advancements has made him a distinguished figure in the field.

Professional Profile

Education

Dr. Mycal Dutta has a strong academic background in pharmacy. He obtained his Ph.D. in Pharmacy from Jahangirnagar University, Dhaka, in December 2022. Prior to this, he completed his Master of Pharmacy (Thesis) degree from Southern University, Bangladesh, in 2011, achieving a CGPA of 3.6 on a 4.0 scale. He earned his Bachelor of Pharmacy (Hons.) degree from the University of Science and Technology Chittagong (USTC) in 2009, graduating with First Class honors. His foundational education includes a Higher Secondary Certificate (HSC) from Govt. Hazi Muhammad Mohsin College, Chittagong, with a GPA of 4.70 out of 5.00 in 2004, and a Secondary School Certificate (SSC) from Collegiate School, Chittagong, with a GPA of 4.38 out of 5.00 in 2002. His educational journey reflects his dedication to academic excellence and pharmaceutical sciences.

Professional Experience

Dr. Mycal Dutta has extensive teaching and research experience in the field of pharmacy. He has been serving as an Associate Professor at the University of Science and Technology Chittagong (USTC) since July 2023. Previously, he worked as an Assistant Professor at BGC Trust University Bangladesh for nearly eight years (2015–2023) and as a Lecturer at the same institution for almost five years (2011–2015). In addition to his teaching roles, he has contributed significantly to academic administration, including serving as an advisor in the Student Welfare Advisory Committee at USTC and as Chief Advisor of the Career Development and Placement Club at BGC Trust University. His professional contributions extend to chairing scientific and publication committees for national conferences and participating in examination committees. His vast experience demonstrates his dedication to pharmacy education and academic leadership.

Research Interests

Dr. Mycal Dutta’s research interests focus on pharmacological and phytochemical investigations of medicinal plants. His work involves compound isolation using techniques such as Nuclear Magnetic Resonance (NMR) and Gas Chromatography-Mass Spectrometry (GC-MS). He is particularly interested in computational drug discovery, molecular docking, Quantitative Structure-Activity Relationship (QSAR) modeling, and ADME/T property analysis of natural compounds. His research aims to bridge wet lab and dry lab approaches to develop therapeutic solutions from natural products. He also explores antimicrobial studies, aseptic techniques, bacterial staining, and in vitro and in vivo pharmacological investigations. His research contributions significantly advance the understanding of bioactive phytochemicals and their therapeutic potential.

Research Skills

Dr. Mycal Dutta possesses a diverse range of research skills, including microbiological techniques such as aseptic handling, bacterial staining, and antimicrobial sensitivity testing. He is proficient in computational drug design, protein modeling, and molecular simulations. His technical expertise extends to animal research, including transgenic and knockout mouse models. He is skilled in using various molecular modeling and Computer-Aided Drug Design (CADD) software. Additionally, he has extensive experience with statistical analysis tools such as GraphPad Prism and SPSS. His proficiency in these areas enables him to conduct high-quality research and mentor students in advanced pharmaceutical investigations.

Awards and Honors

Dr. Mycal Dutta has received several prestigious research grants and recognitions. He was awarded the R&D Grant for Science and Technology (2022–2023) from the Ministry of Science and Technology, Bangladesh, for his research on bioactive phytochemicals. Additionally, he secured a research grant from BGC Trust University Bangladesh in 2017 to support his Ph.D. research. His contributions to pharmaceutical research have been acknowledged through numerous publications in high-impact journals. He has also played a key role in organizing national conferences and scientific symposiums. His commitment to research and academia has earned him a strong reputation in the field of pharmaceutical sciences.

Conclusion

Dr. Mycal Dutta is a dedicated researcher, educator, and pharmaceutical scientist committed to advancing pharmaceutical education and research. With nearly fourteen years of experience, he has made remarkable contributions to pharmacology, phytochemistry, and drug discovery. His extensive research on medicinal plants and computational drug design has positioned him as a leading expert in the field. His passion for teaching, mentoring students, and conducting groundbreaking research continues to impact the pharmaceutical sciences significantly. Through his academic leadership, professional affiliations, and research initiatives, he remains at the forefront of pharmaceutical innovation and education.

Publications Top Notes

  1. Yusuf, A., Shaikat, M. A., Bhuiya, M. A. M., Dutta, M., Nath, A. K., & Dash, P. R. (2023). Utilizing the Medicinal Properties of Delonix regia for Diseases and Beyond: A Review of its Phytochemistry and Pharmacology. Tropical Journal of Natural Product Research, 7(12), 5355–5365. DOI: 10.26538/tjnpr/v7i12.2

  2. Malini, S., Raj, K., Madhumathy, S., El-Hady, K. M., Islam, S., & Dutta, M. (2022). Bioinspired Advances in Nanomaterials for Sustainable Agriculture. Journal of Nanomaterials, 2022, Article ID 8926133. DOI: 10.1155/2022/8926133

  3. Vaidya, S., Jeengar, M., Wadaan, M. A., Mahboob, S., Kumar, P., Reece, L. M., Bathula, S. R., & Dutta, M. (2022). Design and In Vitro Evaluation of Novel Cationic Lipids for siRNA Delivery in Breast Cancer Cell Lines. Evidence-Based Complementary and Alternative Medicine, 2022, Article ID 9231641. DOI: 10.1155/2022/9231641

  4. Jadhav, V., Bhagare, A., Wahab, S., Lokhande, D., Vaidya, C., Dhayagude, A., Khalid, M., Aher, J., Mezni, A., & Dutta, M. (2022). Green Synthesized Calcium Oxide Nanoparticles (CaO NPs) Using Leaves Aqueous Extract of Moringa oleifera and Evaluation of Their Antibacterial Activities. Journal of Nanomaterials, 2022, Article ID 9047507. DOI: 10.1155/2022/9047507

  5. Jadhav, V., Bhagare, A., Ali, I. H., Dhayagude, A., Lokhande, D., Aher, J., Jameel, M., & Dutta, M. (2022). Role of Moringa oleifera on Green Synthesis of Metal/Metal Oxide Nanomaterials. Journal of Nanomaterials, 2022, Article ID 2147393. DOI: 10.1155/2022/2147393

  6. Alharthy, S. A., Shams Tabrez, S., Ahmed A. Mirza, A. A., Torki A. Zughaibi, Firoz, C. K., & Dutta, M. (2022). Sugiol Suppresses the Proliferation of Human U87 Glioma Cells via Induction of Apoptosis and Cell Cycle Arrest. Evidence-Based Complementary and Alternative Medicine, 2022, Article ID 7658899. DOI: 10.1155/2022/7658899

  7. Dutta, M., Akter, T., Nezam, M., Paul, A., & Rana, M. S. (2022). In silico Molecular Docking and ADME/T Analysis of Selected Bioactive Compounds from Leucas zeylanica against Breast Cancer. BGC Trust University Journal, 6, 51–66.

  8. Dutta, M., Tareq, A. M., Rakib, A., Mahmud, S., Sami, S. A., Mallick, J., Islam, M. N., Majumder, M., Uddin, M. Z., Alsubaie, A., & Almalki, A. S. (2021). Phytochemicals from Leucas zeylanica Targeting Main Protease of SARS-CoV-2: Chemical Profiles, Molecular Docking, and Molecular Dynamics Simulations. Biology, 10(8), 789. DOI: 10.3390/biology10080789

  9. Dutta, M., Nezam, M., Chowdhury, S., Rakib, A., Paul, A., Sami, S. A., Uddin, M. Z., Rana, M. S., Hossain, S., Effendi, Y., Idroes, R., Tallei, T. E., Alqahtani, A. M., & Emran, T. B. (2021). Appraisals of the Bangladeshi Medicinal Plant Calotropis gigantea Used by Folk Medicine Practitioners in the Management of COVID-19: A Biochemical and Computational Approach. Frontiers in Molecular Biosciences, 8, 625391. DOI: 10.3389/fmolb.2021.625391

  10. Rakib, A., Paul, A., Ahmed, S., Chy, M. N. U., Baral, S. K., Majumder, M., Tareq, A. T., Amin, M. N., Shahriar, A., Uddin, M. Z., Dutta, M., Tallei, T. E., Emran, T. B., & Simal-Gandara, J. (2020). Biochemical and Computational Approach of Phytocompounds from Tinospora crispa in the Management of COVID-19: Molecules; 25(17): E3936. DOI: 10.3390/molecules25173936